Vav 3 Oncogene (VAV3) Peptide
-
- Target See all VAV3 products
- VAV3 (Vav 3 Oncogene (VAV3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- VAV3 peptide corresponds to 13 amino acids of VAV3.
-
-
- Application Notes
- VAV3 Peptide is used for blocking the activity of VAV3 antibody . The VAV3 antibody ships at 0.5 mg/mL and the VAV3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- VAV3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- VAV3 (Vav 3 Oncogene (VAV3))
- Synonyms
- RGD1565941 Peptide, A530094I06Rik Peptide, AA986410 Peptide, Idd18.1 Peptide, vav guanine nucleotide exchange factor 3 Peptide, vav 3 guanine nucleotide exchange factor Peptide, vav 3 oncogene Peptide, VAV3 Peptide, Vav3 Peptide
- Gene ID
- 10451
- NCBI Accession
- NP_006104
- OMIM
- 120432044
- UniProt
- Q9UKW4
-